101 related articles for article (PubMed ID: 1651806)
1. Familial aggregation of nasopharyngeal carcinoma and other malignancies. A clinicopathologic description.
Coffin CM; Rich SS; Dehner LP
Cancer; 1991 Sep; 68(6):1323-8. PubMed ID: 1651806
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Risk Factors for Nasopharyngeal Carcinoma in a High-risk Area of India, the Northeastern Region.
Lourembam DS; Singh AR; Sharma TD; Singh TS; Singh TR; Singh LS
Asian Pac J Cancer Prev; 2015; 16(12):4927-35. PubMed ID: 26163617
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.
Pickard A; Chen CJ; Diehl SR; Liu MY; Cheng YJ; Hsu WL; Sun B; Hsu MM; Chen IH; Chen JY; Yang CS; Mittl BL; Chou SP; Ruggles DD; Goldstein AM; Hildesheim A
Int J Cancer; 2004 Aug; 111(1):117-23. PubMed ID: 15185352
[TBL] [Abstract][Full Text] [Related]
4. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and viral studies in nasopharyngeal carcinomas in patients of Indian origin.
Kumari P; Augustus M; Naik U; Ravi V; Shenoy AM; Rao CR; Kumar RV
Indian J Cancer; 1995 Mar; 32(1):10-4. PubMed ID: 7558105
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
7. Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.
Ban EZ; Lye MS; Chong PP; Yap YY; Lim SYC; Abdul Rahman H
PLoS One; 2017; 12(11):e0187200. PubMed ID: 29121049
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal carcinoma in an Alaskan Eskimo family: report of three cases.
Lanier AP; Bender TR; Tschopp CF; Dohan P
J Natl Cancer Inst; 1979 May; 62(5):1121-4. PubMed ID: 220446
[TBL] [Abstract][Full Text] [Related]
9. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
[TBL] [Abstract][Full Text] [Related]
10. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC.
Simons MJ; Wee GB; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
IARC Sci Publ (1971); 1975; (11 Pt 2):249-58. PubMed ID: 191368
[TBL] [Abstract][Full Text] [Related]
11. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency.
Chen CJ; Liang KY; Chang YS; Wang YF; Hsieh T; Hsu MM; Chen JY; Liu MY
Anticancer Res; 1990; 10(2B):547-53. PubMed ID: 2161639
[TBL] [Abstract][Full Text] [Related]
12. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G
Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
[TBL] [Abstract][Full Text] [Related]
14. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
Cheng YC; Chen JY; Glaser R; Henle W
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
[TBL] [Abstract][Full Text] [Related]
15. Contribution of susceptibility locus at HLA class I region and environmental factors to occurrence of nasopharyngeal cancer in Northeast India.
Lakhanpal M; Singh LC; Rahman T; Sharma J; Singh MM; Kataki AC; Verma S; Chauhan PS; Singh YM; Wajid S; Kapur S; Saxena S
Tumour Biol; 2015 Apr; 36(4):3061-73. PubMed ID: 25514873
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma, aplastic anemia, and various malignancies in a family: possible role of Epstein-Barr virus.
Schimke RN; Collins D; Cross D
Am J Med Genet; 1987 May; 27(1):195-202. PubMed ID: 3037902
[TBL] [Abstract][Full Text] [Related]
17. [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma].
Guo XC; O'Brien SJ; Winkler C; Scott K; Hutcheson H; David V; Kessing B; Zheng YM; Liao J; Lui Y; Guy de T; Zeng Y
Yi Chuan; 2006 Jul; 28(7):783-90. PubMed ID: 16825163
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
19. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.
Feng BJ; Huang W; Shugart YY; Lee MK; Zhang F; Xia JC; Wang HY; Huang TB; Jian SW; Huang P; Feng QS; Huang LX; Yu XJ; Li D; Chen LZ; Jia WH; Fang Y; Huang HM; Zhu JL; Liu XM; Zhao Y; Liu WQ; Deng MQ; Hu WH; Wu SX; Mo HY; Hong MF; King MC; Chen Z; Zeng YX
Nat Genet; 2002 Aug; 31(4):395-9. PubMed ID: 12118254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
